MIMEDX GROUP, INC.
For the period ended Jun 30, 2026. Filed Jul 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
There have been no material changes to the Company’s risk factors included in the 2025 Form 10-K.
(a) None.
(b) None.
(c) The following table sets forth information regarding the purchases of the Company’s equity securities by or on behalf of the Company or any affiliated purchaser (as defined in Exchange Act Rule 10b-18) during the three month period ended June 30, 2026.
| Period | Total number of shares repurchased | Average price paid per share | Total number of shares (or units) purchased as part of publicly announced plans or programs | Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs. |
|---|---|---|---|---|
| April 1 - April 30, 2026 | — | $— | — | $100,000,000 |
| May 1 - May 31, 2026 | 1,770,684 | 3.62 | 1,770,684 | 93,590,124 |
| June 1 - June 30, 2026 | 1,693,715 | 3.71 | 1,693,715 | 87,306,441 |
| Total for the quarter | 3,464,399 | $3.67 | 3,464,399 | $87,306,441 |
Repurchases during the quarter were made pursuant to a $100 million authorization which was announced on February 25, 2026 and will expire in February 2028.
Not applicable.
Not applicable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.